Men's Health

Novel assay may help identify prostate Bx candidatesA simple blood test that measures PSA structure rather than concentration may be more accurate than PSA in identifying men who need a prostate biopsy, according to the results of a study presented at the Genitourinary Cancers Symposium in Orlando, FL.
Role of molecular biomarkers in localized prostate cancer
Hypofractionated IMRT outcomes comparable to standard regimen“We showed that we can safely compress radiation into a shorter time frame, into fewer treatments, at higher dose per fraction, with similar clinical outcomes and similar toxicity profiles,” said researcher Michael Wang, MD.
TRT and heart health: Conflicting findings publishedRecently published studies also evaluated testosterone replacement therapy’s effect on anemia, cognitive function, and bone density and strength.
Testosterone therapy's big week: One urologist's perspectiveAbraham Morgentaler, MD, shares why the recent publication of five studies on testosterone therapy in JAMA and JAMA Internal Medicine "was arguably the most important week ever for the science of testosterone therapy and its impact on men's health."
Researchers validate prognostic model for mCRPCResearchers have developed and validated a clinically useful prognostic model for men with metastatic castration-resistant prostate cancer, which can be used in the front-line setting.
Men’s health: A forgotten topicIn many ways, policymakers, insurance companies, and certain health care providers seem to have a total disregard for men’s health, writes Henry Rosevear, MD.
Ureteroscopy may adversely affect erectile functionResults of a retrospective study raise concern that ureteroscopy may adversely affect erectile function.
Day of RP affects complication rates, length of stayRadical prostatectomy performed on a Friday is associated with a higher complication rate and extended hospital stay compared with the same surgery performed on other days of the week.
Testis Ca care deviates from guidelines in 30% of patientsNearly one-third of men with testicular cancer undergo diagnostic or therapeutic interventions that are at odds with guidelines from the National Comprehensive Cancer Network (NCCN), according a study published in the Journal of Urology (2017; 197:684-9).